Livedoid Thrombotic Vasculopathy Responding to Doxycycline Therapy

Overview

Journal J Clin Aesthet Dermatol

Date 2011 Jan 8

PMID 21212844

Citations 1

Authors

Matthew S Keller

Jason Lee

Guy F Webster

Affiliations

Soon will be listed here.

Abstract

Livedoid vasculopathy is a disease of the lower extremities that occurs predominantly in women. It begins as purpura and eventually ulcerates. Multiple causes have been posited, but many cases are found to be idiopathic. Many treatment modalities have been attempted to control the disease process, but many cases remain difficult to treat, and, at times, the treatments have side effects that limit treatment. This is a case report in a small number of patients tested in unblinded fashion. We report the effective use of doxycycline in the treatment of long-standing livedoid vasculopathy in two patients.

Citing Articles

Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Bilgic A, Ozcobanoglu S, Bozca B, Alpsoy E Int J Womens Dermatol. 2022; 7(5Part A):588-599.

PMID: 35024414 PMC: 8721056. DOI: 10.1016/j.ijwd.2021.08.013.

References

SAUER G . Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol. 1986; 122(4):380-1. View

Webster G, Del Rosso J . Anti-inflammatory activity of tetracyclines. Dermatol Clin. 2007; 25(2):133-5, v. DOI: 10.1016/j.det.2007.01.012. View

Juan W, Chan Y, Lee J, Yang L, Hong H, Yang C . Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy. Br J Dermatol. 2006; 154(2):251-5. DOI: 10.1111/j.1365-2133.2005.06843.x. View

BARD J, Winkelmann R . Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis. Arch Dermatol. 1967; 96(5):489-99. DOI: 10.1001/archderm.96.5.489. View

Shornick J, Nicholes B, Bergstresser P, Gilliam J . Idiopathic atrophie blanche. J Am Acad Dermatol. 1983; 8(6):792-8. DOI: 10.1016/s0190-9622(83)80008-5. View

Hairston B, Davis M, Pittelkow M, Ahmed I . Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol. 2006; 142(11):1413-8. DOI: 10.1001/archderm.142.11.1413. View

McCalmont C, McCalmont T, Jorizzo J, White W, Leshin B, Rothberger H . Livedo vasculitis: vasculitis or thrombotic vasculopathy?. Clin Exp Dermatol. 1992; 17(1):4-8. DOI: 10.1111/j.1365-2230.1992.tb02522.x. View

Winkelmann R, Schroeter A, KIERLAND R, Ryan T . Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo Clin Proc. 1974; 49(10):746-50. View

Callen J . Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol. 2006; 142(11):1481-2. DOI: 10.1001/archderm.142.11.1481. View

10.

KERN A . Atrophie blanche. Report of two patients treated with aspirin and dipyridamole. J Am Acad Dermatol. 1982; 6(6):1048-53. View

11.

Browning C, Callen J . Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol. 2006; 142(1):75-8. DOI: 10.1001/archderm.142.1.75. View

12.

Stevanovic D . Atrophie blanche. A sign of dermal blood occlusion. Arch Dermatol. 1974; 109(6):858-62. View

13.

Webster G, Toso S, Hegemann L . Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch Dermatol. 1994; 130(6):748-52. View

14.

Pizzo S, Murray J, Gonias S . Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med. 1986; 110(6):517-9. View

15.

Schanz S, Ulmer A, Fierlbeck G . Intravenous immunoglobulin in livedo vasculitis: a new treatment option?. J Am Acad Dermatol. 2003; 49(3):555-6. DOI: 10.1067/s0190-9622(03)00785-0. View

16.

Hegemann B, Helmbold P, Marsch W . Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. Arch Dermatol. 2002; 138(6):841-2. DOI: 10.1001/archderm.138.6.841. View

17.

Bastos L, Merlo L, Rocha L, Coelho M . Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models. Eur J Pharmacol. 2007; 576(1-3):171-9. DOI: 10.1016/j.ejphar.2007.07.049. View

18.

Weinberg J . The anti-inflammatory effects of tetracyclines. Cutis. 2005; 75(4 Suppl):6-11. View